McKinsey October 8, 2024
Anna Koivuniemi, Matt Fitzpatrick i

Anna Koivuniemi of Google DeepMind explores how AI can revolutionize industries, benefit society, and drive scientific breakthroughs, while emphasizing the critical need for safety and responsible use.

Proteins are vital molecules that perform a wide range of functions essential for life. But since the late 1950s, even with the help of supercomputers, humans have only been able to predict the structure of around 200,000 proteins. Fast forward to today, and in just a few short years, Google DeepMind’s AI model has dramatically increased that number to 200 million structures.

Anna Koivuniemi, who leads Google DeepMind’s Impact Accelerator, recently met with Matt Fitzpatrick, senior partner and global leader of QuantumBlack Labs, the R&D and software development group within QuantumBlack. They discussed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma / Biotech, Technology, Trends
Related Articles:
The case for human-centered AI
European Commission Approves Nvidia’s Proposed Acquisition of Run:ai
How Health Systems Can Collaborate on AI Tools
The Future Talent Equation: How To Identify And Retain Talent In The Age Of AI
A Roadmap For AI In Education: Turning Disruption Into Opportunity

Share This Article